Filing Flows › Comparisons › VTVT vs ATNM
vTv Therapeutics vs Actinium Pharmaceuticals: VTVT and ATNM compared
vTv Therapeutics is the larger company: $36.8M of revenue in its latest quarter (Q1 2026) against $35.0M for Actinium Pharmaceuticals (Q2 2026). Actinium Pharmaceuticals is more profitable, with an operating margin of 78.8% against 63.1%.
Where the money goes: VTVT and ATNM
vTv Therapeutics (VTVT) · Q1 2026
vTv Therapeutics, Q1 2026: revenue $36.8M, operating margin 63.1%, net earnings $24.1M, operating cash flow $9.2M. The chart follows the revenue to costs, profit and cash.
Actinium Pharmaceuticals (ATNM) · Q2 2026
Actinium Pharmaceuticals, Q2 2026: revenue $35.0M, operating margin 78.8%, net earnings $27.9M, operating cash flow −$5.2M. The chart follows the revenue to costs, profit and cash.
| vTv Therapeutics (VTVT) | Actinium Pharmaceuticals (ATNM) | |
|---|---|---|
| Latest quarter | Q1 2026 | Q2 2026 |
| Revenue | $36.8M | $35.0M |
| Operating margin | 63.1% | 78.8% |
| Net earnings | $24.1M | $27.9M |
| Net margin | 65.5% | 79.7% |
| Operating cash flow | $9.2M | −$5.2M |
Questions
Which is bigger, vTv Therapeutics or Actinium Pharmaceuticals?
vTv Therapeutics is the larger company: $36.8M of revenue in its latest quarter (Q1 2026) against $35.0M for Actinium Pharmaceuticals (Q2 2026).
Is vTv Therapeutics or Actinium Pharmaceuticals growing faster?
Actinium Pharmaceuticals is more profitable, with an operating margin of 78.8% against 63.1%.
More: vTv Therapeutics earnings · how vTv Therapeutics makes money · Actinium Pharmaceuticals earnings · how Actinium Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed May 13, 2026; 10-Q filed Aug 7, 2026). Fiscal quarters can end on different dates. Not investment advice.